Chemical Structure : AVL-292
CAS No.: 1202757-89-8
货号: PC-45401Not For Human Use, Lab Use Only.
AVL-292 (Spebrutinib, CC-292) is a highly selective, covalent Btk inhibitor with IC50 of <1 nM.
规格 | 价格 | 库存 | 数量 |
---|---|---|---|
10 mg | ¥880 | In stock | |
25 mg | ¥1380 | In stock | |
50 mg | ¥2180 | In stock | |
100 mg | ¥3580 | In stock | |
250 mg | Get quote |
大包装,大折扣!
E-mail: sales@probechem.com
Tech Support: tech@probechem.com
AVL-292 (Spebrutinib, CC-292) is a highly selective, covalent Btk inhibitor with IC50 of <1 nM.
AVL-292 (Spebrutinib, CC-292) also less potently inhibits Yes, c-Src, Brk, Lyn, and Fyn with IC50s of 723 nM, 1.729 uM, 2.43 uM, 4.4 uM, and 7.15 uM, rspectively.
AVL-292 (Spebrutinib, CC-292) shows anti-inflammatory activity in the collagen-induced arthritis model of autoimmune disease.
AVL-292 (Spebrutinib, CC-292) also prevents NRG- and EGF-dependent growth factor-driven resistance to lapatinib in HER2(+) breast cancer cells.
分子量 | 423.4402 | |
分子式 | C22H22FN5O3 | |
外观性状 | Solid | |
储存条件 |
|
|
Solubility |
DMSO: ≥ 45 mg/mL |
|
Chemical Name/SMILES |
2-Propenamide, N-[3-[[5-fluoro-2-[[4-(2-methoxyethoxy)phenyl]amino]-4-pyrimidinyl]amino]phenyl]- |
1. Evans EK, et al. J Pharmacol Exp Ther. 2013 Aug;346(2):219-28.
2. Eda H, et al. Leukemia. 2014 Sep;28(9):1892-901.
3. Wang X, et al. Mol Cancer Ther. 2016 Sep;15(9):2198-208.
备案号:沪ICP备16042516号-1 Copyright © 2022 probechem.com. All Rights Reserved. probechem Copyright